While more than 100 House and Senate members have sent letters to CMS expressing their concern about the new rule, the bipartisan group at the news conference called for new legislation addressing the issue.
At an NCPA press conference mid-May, 10 members of the House pledged to support the association's efforts to revamp proposed Medicaid pharmacy reimbursement. In July, CMS is expected to implement a new rule, which will change Medicaid reimbursement and begin using average manufacturer price (AMP). GAO recently calculated that the way CMS plans to use AMP would reimburse pharmacies 36% below the acquisition cost. While more than 100 House and Senate members have sent letters to CMS expressing their concern about the new rule, the bipartisan group at the news conference called for new legislation addressing the issue. "A letter isn't enough," insisted Rep. Nancy Boyda (D, Kan.). "We must take legislative action." Rep. Virginia Foxx (R, N.C.) added, "This plan for reimbursement is pennywise and pound-foolish, and we need to change the system."
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.